6min chapter

Hematologic Oncology Update cover image

Inside the Issue: The Current and Future Role of CD20 x CD3 Bispecific Antibodies in the Management of Non-Hodgkin Lymphoma

Hematologic Oncology Update

CHAPTER

CD20 x CD3 Bispecific Antibodies in Non-Hodgkin Lymphoma Management

This chapter discusses the role of CD20 x CD3 bispecific antibodies in the management of Non-Hodgkin Lymphoma, including education and support provided by companies, guidelines developed by the Lymphoma Research Foundation, sequencing of therapy for FL, measuring CD20 expression, and potential cytokine release syndrome.

00:00

Get the Snipd
podcast app

Unlock the knowledge in podcasts with the podcast player of the future.
App store bannerPlay store banner

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode

Save any
moment

Hear something you like? Tap your headphones to save it with AI-generated key takeaways

Share
& Export

Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode